NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AllianceBernstein Holding L.P. (NYSE:AB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), Ply Gem Holdings, Inc. (NYSE:PGEM), Ensco plc (NYSE:ESV), and Berkshire Hills Bancorp, Inc. (NYSE:BHLB), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
AB DOWNLOAD: http://Fundamental-Markets.com/register/?so=AB
DB DOWNLOAD: http://Fundamental-Markets.com/register/?so=DB
SYRS DOWNLOAD: http://Fundamental-Markets.com/register/?so=SYRS
PGEM DOWNLOAD: http://Fundamental-Markets.com/register/?so=PGEM
ESV DOWNLOAD: http://Fundamental-Markets.com/register/?so=ESV
BHLB DOWNLOAD: http://Fundamental-Markets.com/register/?so=BHLB
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine AllianceBernstein Holding L.P. (NYSE:AB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), Ply Gem Holdings, Inc. (NYSE:PGEM), Ensco plc (NYSE:ESV), and Berkshire Hills Bancorp, Inc. (NYSE:BHLB) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 23rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ALLIANCEBERNSTEIN HOLDING L.P. (AB) REPORT OVERVIEW
AllianceBernstein Holding's Recent Financial Performance
AllianceBernstein Holding is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.46. The estimated EPS forecast for the next fiscal year is $2.66 and is expected to report on February 12th, 2019.
To read the full AllianceBernstein Holding L.P. (AB) report, download it here: http://Fundamental-Markets.com/register/?so=AB
-----------------------------------------
DEUTSCHE BANK AKTIENGESELLSCHAFT (DB) REPORT OVERVIEW
Deutsche Bank Aktiengesellschaft's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Deutsche Bank Aktiengesellschaft reported interest income of $7,669.65MM vs $7,027.42MM (up 9.14%) and basic earnings per share -$0.28 vs -$1.49. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Deutsche Bank Aktiengesellschaft reported interest income of $27,231.19MM vs $28,368.80MM (down 4.01%) and basic earnings per share $0.60 vs -$1.34. Deutsche Bank Aktiengesellschaft is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.42. The estimated EPS forecast for the next fiscal year is $1.64 and is expected to report on March 15th, 2019.
To read the full Deutsche Bank Aktiengesellschaft (DB) report, download it here: http://Fundamental-Markets.com/register/?so=DB
-----------------------------------------
SYROS PHARMACEUTICALS, INC. (SYRS) REPORT OVERVIEW
Syros Pharmaceuticals' Recent Financial Performance
For the twelve months ended December 31st, 2017 vs December 31st, 2016, Syros Pharmaceuticals reported revenue of $1.10MM vs $0.32MM (up 247.32%) and basic earnings per share -$2.13 vs -$4.05. Syros Pharmaceuticals is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.49. The estimated EPS forecast for the next fiscal year is -$2.47 and is expected to report on March 11th, 2019.
To read the full Syros Pharmaceuticals, Inc. (SYRS) report, download it here: http://Fundamental-Markets.com/register/?so=SYRS
-----------------------------------------
PLY GEM HOLDINGS, INC. (PGEM) REPORT OVERVIEW
Ply Gem's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Ply Gem reported revenue of $516.86MM vs $462.29MM (up 11.80%) and basic earnings per share $0.21 vs $0.10 (up 110.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ply Gem reported revenue of $2,056.30MM vs $1,911.84MM (up 7.56%) and basic earnings per share $1.00 vs $1.11 (down 9.91%). Ply Gem is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.04. The estimated EPS forecast for the next fiscal year is $2.03 and is expected to report on March 4th, 2019.
To read the full Ply Gem Holdings, Inc. (PGEM) report, download it here: http://Fundamental-Markets.com/register/?so=PGEM
-----------------------------------------
ENSCO PLC (ESV) REPORT OVERVIEW
Ensco plc's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Ensco plc reported revenue of $454.20MM vs $504.60MM (down 9.99%) and basic earnings per share -$0.59 vs $0.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ensco plc reported revenue of $1,843.00MM vs $2,776.40MM (down 33.62%) and basic earnings per share -$0.91 vs $3.13. Ensco plc is expected to report earnings on April 25th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.04. The estimated EPS forecast for the next fiscal year is -$0.93 and is expected to report on February 25th, 2019.
To read the full Ensco plc (ESV) report, download it here: http://Fundamental-Markets.com/register/?so=ESV
-----------------------------------------
BERKSHIRE HILLS BANCORP, INC. (BHLB) REPORT OVERVIEW
Berkshire Hills' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Berkshire Hills reported interest income of $105.82MM vs $72.43MM (up 46.10%) and basic earnings per share -$0.14 vs $0.32. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Berkshire Hills reported interest income of $360.26MM vs $280.44MM (up 28.46%) and basic earnings per share $1.40 vs $1.89 (down 25.93%). Berkshire Hills is expected to report earnings on April 23rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.55. The estimated EPS forecast for the next fiscal year is $3.07 and is expected to report on January 24th, 2019.
To read the full Berkshire Hills Bancorp, Inc. (BHLB) report, download it here: http://Fundamental-Markets.com/register/?so=BHLB
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.